Press Release

Tryg – Transactions in connection with share buyback programme

On 22 January 2026, Tryg A/S (“Tryg”) announced that the Board of Directors had decided to initiate a share buyback programme of up to DKK 1.0 billion. The share buyback programme is executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour...

Trading in Sampo A shares on Nasdaq Stockholm has begun

Sampo plc, press release, 16 February 2026 at 11:00 am EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR...
spot_img

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease...

― Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at the Week 6 timepoint (n=12): mean absolute HbF in...

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of death by more than half compared to standard of care chemotherapy and...

Geekstake Reviews Risk Signals Across Multi-Chain Networks in Response to Global Economic Uncertainty

New York, USA, Dec. 06, 2025 (GLOBE NEWSWIRE) -- GeekStake today released a macro-level market update examining risk indicators across...

ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20...

Highly differentiated 1L preliminary systemic activity of 67% ORR and 100% intracranial ORR (by BICR-RANO), including in patients with active brain metastases 45%...

Copper Quest Closes $1,927,000 Private Placement

// Not for distribution to the United States newswire services or for dissemination in the United States // VANCOUVER, British Columbia, Dec. ...

HNI Corporation Announces Expiration and Final Results of Exchange Offer

MUSCATINE, Iowa, Dec. 05, 2025 (GLOBE NEWSWIRE) -- On August 4, 2025, HNI Corporation (NYSE: HNI; “HNI”) announced a definitive agreement to...

Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group

New York, USA, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Webus International Limited (“Webus” or the “Company”) provides the following clarification regarding...

Colabor Group Announces Resignation of Director

SAINT-BRUNO-DE-MONTARVILLE, Quebec, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) announces that Ms. Danièle Bergeron...

ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical...

Highly differentiated 1L EGFR PACC preliminary systemic activity of 80% ORR and 100% intracranial ORR, including in patients with active brain metastases 36%...

Transcenta Therapeutics Presents Updated Efficacy Data from the Phase I/II Transtar102 Trial of Osemitamab plus Nivolumab and CAPOX in First-Line G/GEJ Cancer at ESMO...

Data showed encouraging results in patients with higher CLDN18.2 expression regardless of PD-L1 expression level, with a median PFS of 16.6 months, ORR of...

CEA Industries (Nasdaq: BNC) Responds to YZi Labs, Re-Affirms Commitment to BNB DAT Strategy, and Welcomes Shareholder Engagement

Shareholders do not need to take any action at this time Louisville, CO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- CEA Industries...

Miata Metals Announces Filing of Final Short Form Prospectus – Accessible on SEDAR+

Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 04, 2025 ...
error: